In vivo CAR T cells and targeted gene delivery: A theme for the Pharmaceuticals and Medical Devices Agency Science Board to address

In vivo CAR T cells and targeted gene delivery: A theme for the Pharmaceuticals and Medical Devices Agency Science Board to address

Bibliographic Details
Main Authors:	Rika Wakao, Ai Fukaya-Shiba
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Medicine
Subjects:	regulatory science horizon scanning drug development CAR T cell gene therapy targeted gene delivery
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1141880/full

Similar Items

Identification of Novel Modalities Through Bibliometric Analysis for Timely Development of Regulatory Guidance: A Case Study of T Cell Immunity
by: Ai Fukaya-Shiba, et al.
Published: (2021-10-01)

Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products
by: Francisco D. Rodríguez-Gómez, et al.
Published: (2024-01-01)

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
by: Tianqing Xin, et al.
Published: (2022-02-01)

Science and societal partnerships to address cumulative impacts
by: Carolyn J Lundquist, et al.
Published: (2016-02-01)

Allogeneic CAR-T Cells: More than Ease of Access?
by: Charlotte Graham, et al.
Published: (2018-10-01)

In vivo generated human CAR T cells eradicate tumor cells
by: Shiwani Agarwal, et al.
Published: (2019-12-01)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
by: Motahareh Arjomandnejad, et al.
Published: (2022-01-01)

Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
by: Katharina Eva Ruppel, et al.
Published: (2022-03-01)

Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
by: Motahareh Arjomandnejad, et al.
Published: (2021-12-01)

Health horizons: Future trends and technologies from the European Medicines Agency’s horizon scanning collaborations
by: Valentina Vignali, et al.
Published: (2022-12-01)

Mutations in immunodeficiency-related genes may increase the risk of infection after CAR-T-cell therapy: a report of two cases
by: Di Wang, et al.
Published: (2023-02-01)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
by: Alexander Dimitri, et al.
Published: (2022-03-01)

Advantages and Applications of CAR-Expressing Natural Killer Cells
by: Wolfgang eGlienke, et al.
Published: (2015-02-01)

CRISPR/Cas9 encouraged CAR-T cell immunotherapy reporting efficient and safe clinical results towards cancer
by: Afreen Khan, et al.
Published: (2022-01-01)

Inferring gene regulatory networks using Dynamic Bayesian Network with Markov Chain Monte Carlo algorithm /
by: Low, Swee Thing, 1989- , author, et al.
Published: (2013)

The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology
by: Yasmin R. Mohseni, et al.
Published: (2020-07-01)

The Kraken in the Aquarium: questions that urgently need to be addressed in order to advance marine conservation
by: John A. Cigliano, et al.
Published: (2016-09-01)

Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus
by: Craig M. Rive, et al.
Published: (2022-09-01)

Analysis of causes for poor persistence of CAR-T cell therapy in vivo
by: Yingjie Kong, et al.
Published: (2023-01-01)

CRISPR, CAR-T, and NK: Current applications and future perspectives
by: Mohadeseh Khoshandam, et al.
Published: (2024-07-01)

Horizon Scanning of Oncology Drugs in Iran in 2015
by: Bayan Hosseini, et al.
Published: (2018-01-01)

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
by: Xu N, et al.
Published: (2021-04-01)

Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation
by: Xiaojun Liu, et al.
Published: (2017-05-01)

Common Themes and Future Challenges in Understanding Gene Regulatory Network Evolution
by: Isabella Schember, et al.
Published: (2022-02-01)

Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators
by: Robbe Saesen, et al.
Published: (2023-05-01)

Drivers’ Perspectives of Car Dependence
by: David Metz
Published: (2023-07-01)

Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy
by: Zixin Lv, et al.
Published: (2023-07-01)

Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
by: Zhengchao Zhang, et al.
Published: (2021-07-01)

Review: Sustainable Clinical Development of CAR-T Cells – Switching From Viral Transduction Towards CRISPR-Cas Gene Editing
by: Dimitrios L. Wagner, et al.
Published: (2022-06-01)

Revisiting the CompCars Dataset for Hierarchical Car Classification: New Annotations, Experiments, and Results
by: Marco Buzzelli, et al.
Published: (2021-01-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Kevin Pan, et al.
Published: (2022-03-01)

Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo
by: Jin-Yuan Ho, et al.
Published: (2021-06-01)

CAR-T: What Is Next?
by: Yi-Ju Chen, et al.
Published: (2023-01-01)

CAR Chase: Where Do Engineered Cells Go in Humans?
by: Simone Krebs, et al.
Published: (2020-09-01)

Inferring gene regulatory networks using Dynamic Bayesian Network with Markov Chain Monte Carlo algorithm [electronic resource] /
by: Low, Swee Thing, 1989-, author
Published: (2013)

A new hyper-heuristic algorithm for gene sequence assembly /
by: Nurhafiza Rosdi, 1991-, author 604985, et al.
Published: (2016)

A new hyper-heuristic algorithm for gene sequence assembly /
by: Nurhafiza Rosdi, 1991-, author 604985
Published: (2016)

The role of master regulators in gene regulatory networks
by: Enrique Hernández Lemus, et al.
Published: (2015-05-01)

Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients
by: Alexander Kunz, et al.
Published: (2020-06-01)

Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?
by: Chiara F. Magnani, et al.
Published: (2020-05-01)